Analyzing CITE-seq data like an immunologist with a hybrid hierarchical gating approach in CellEngine software

Home > Science Hub > Analyzing CITE-seq data like an immunologist with a hybrid hierarchical gating approach in CellEngine software
Back to the list

October 29, 2024

Matt Clutter

You might also be interested by

Press Releases

CellCarta and Pillar Biosciences Announce Multi-Year Global Strategic Partnership to Expand Rapid, Decentralized Tumor Profiling for Oncology Clinical Trials

April 7, 2026

More info

News

CellCarta and Lunit Announce Strategic Collaboration to Accelerate AI-Enabled Digital Pathology for Companion Diagnostic Programs

March 30, 2026

More info

News

CellCarta Secures Global Exclusivity for Biofidelity's Aspyre® Lung to Advance Targeted Lung Cancer Testing

March 18, 2026

More info

Posters

Validation of an ultra-sensitive assay for biomarker testing in NSCLC patients as Clinical Trial Assay (CTA)

March 3, 2026

More info